Nxera Pharma Co., Ltd. (4565.T)
JPY 1056.0
(1.15%)
JPY 1056.0
(1.15%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -87.17 JPY | -1966.6% |
| 2022 | 4.67 JPY | -62.73% |
| 2021 | 12.53 JPY | -33.28% |
| 2020 | 18.78 JPY | 0.48% |
| 2019 | 18.69 JPY | 117.92% |
| 2018 | -104.29 JPY | -177.74% |
| 2017 | -37.55 JPY | -127.25% |
| 2016 | 137.79 JPY | 645.06% |
| 2015 | -25.28 JPY | -369.51% |
| 2014 | 9.38 JPY | -70.37% |
| 2013 | 31.66 JPY | 332.28% |
| 2012 | -13.63 JPY | 66.99% |
| 2011 | -41.29 JPY | -4.08% |
| 2010 | -39.67 JPY | -5.76% |
| 2009 | -37.51 JPY | 55.09% |
| 2008 | -83.52 JPY | 39.54% |
| 2007 | -138.14 JPY | 10.76% |
| 2006 | -154.79 JPY | -23.34% |
| 2005 | -125.50 JPY | -56.21% |
| 2004 | -80.34 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -15.86 JPY | 56.76% |
| 2024 Q3 | 13.35 JPY | 184.17% |
| 2024 Q1 | -36.68 JPY | -1474.25% |
| 2023 Q2 | -8.01 JPY | 53.19% |
| 2023 FY | - JPY | -1966.6% |
| 2023 Q3 | -59.82 JPY | -646.82% |
| 2023 Q1 | -17.11 JPY | -138.86% |
| 2023 Q4 | -2.33 JPY | 96.1% |
| 2022 FY | - JPY | -62.73% |
| 2022 Q4 | 44.03 JPY | 1052.62% |
| 2022 Q3 | 3.82 JPY | 121.27% |
| 2022 Q2 | -17.96 JPY | 29.26% |
| 2022 Q1 | -25.39 JPY | -172.52% |
| 2021 FY | - JPY | -33.28% |
| 2021 Q4 | 35.01 JPY | 503.62% |
| 2021 Q3 | 5.80 JPY | 141.11% |
| 2021 Q1 | -14.28 JPY | -136.62% |
| 2021 Q2 | -14.11 JPY | 1.19% |
| 2020 FY | - JPY | 0.48% |
| 2020 Q1 | -9.69 JPY | -2450.0% |
| 2020 Q2 | -17.76 JPY | -83.28% |
| 2020 Q3 | 5.94 JPY | 133.45% |
| 2020 Q4 | 39.00 JPY | 556.57% |
| 2019 Q2 | -8.14 JPY | -161.02% |
| 2019 Q1 | 13.34 JPY | 138.41% |
| 2019 FY | - JPY | 117.92% |
| 2019 Q3 | 13.88 JPY | 270.52% |
| 2019 Q4 | -0.38 JPY | -102.74% |
| 2018 Q3 | -27.16 JPY | -32.04% |
| 2018 FY | - JPY | -177.74% |
| 2018 Q2 | -20.57 JPY | -47.77% |
| 2018 Q1 | -13.92 JPY | 22.58% |
| 2018 Q4 | -34.73 JPY | -27.87% |
| 2017 Q1 | -14.44 JPY | -1839.76% |
| 2017 FY | - JPY | -127.25% |
| 2017 Q4 | -17.98 JPY | -45.82% |
| 2017 Q3 | -12.33 JPY | -385.42% |
| 2017 Q2 | 4.32 JPY | 129.92% |
| 2016 FY | - JPY | 645.06% |
| 2016 Q3 | -7.46 JPY | -104.51% |
| 2016 Q4 | 0.83 JPY | 111.13% |
| 2016 Q2 | 165.27 JPY | 388.33% |
| 2016 Q1 | -57.32 JPY | -214.21% |
| 2015 FY | - JPY | -369.51% |
| 2015 Q1 | 5.45 JPY | 28.24% |
| 2015 Q2 | -14.72 JPY | -370.09% |
| 2015 Q3 | -0.53 JPY | 96.4% |
| 2015 Q4 | 50.19 JPY | 9569.81% |
| 2014 Q4 | 4.25 JPY | 77.08% |
| 2014 Q1 | 35.09 JPY | 561.1% |
| 2014 FY | - JPY | -70.37% |
| 2014 Q2 | -1.89 JPY | -105.39% |
| 2014 Q3 | 2.40 JPY | 226.98% |
| 2013 Q4 | -7.61 JPY | -163.95% |
| 2013 FY | - JPY | 332.28% |
| 2013 Q2 | -12.75 JPY | -35.93% |
| 2013 Q1 | -9.38 JPY | -1984.44% |
| 2013 Q3 | 11.90 JPY | 193.33% |
| 2012 Q1 | -12.39 JPY | 4.18% |
| 2012 FY | - JPY | 66.99% |
| 2012 Q2 | -13.81 JPY | -11.46% |
| 2012 Q4 | -0.45 JPY | -104.49% |
| 2012 Q3 | 10.03 JPY | 172.63% |
| 2011 Q4 | -12.93 JPY | -173.36% |
| 2011 Q3 | -4.73 JPY | 57.88% |
| 2011 Q2 | -11.23 JPY | 20.47% |
| 2011 Q1 | -14.12 JPY | -13.05% |
| 2011 FY | - JPY | -4.08% |
| 2010 Q1 | -15.76 JPY | -39.59% |
| 2010 Q2 | 0.22 JPY | 101.4% |
| 2010 Q3 | -13.30 JPY | -6145.45% |
| 2010 FY | - JPY | -5.76% |
| 2010 Q4 | -12.49 JPY | 6.09% |
| 2009 Q2 | 5.85 JPY | 168.34% |
| 2009 Q3 | -16.31 JPY | -378.8% |
| 2009 Q4 | -11.29 JPY | 30.78% |
| 2009 FY | - JPY | 55.09% |
| 2009 Q1 | -8.56 JPY | 76.16% |
| 2008 Q4 | -35.90 JPY | -84.67% |
| 2008 FY | - JPY | 39.54% |
| 2008 Q3 | -19.44 JPY | 0.0% |
| 2007 FY | - JPY | 10.76% |
| 2006 FY | - JPY | -23.34% |
| 2005 FY | - JPY | -56.21% |
| 2004 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 194.544% |
| PRISM BioLab Co.,LTD | -14.90 JPY | -485.034% |
| GNI Group Ltd. | 169.50 JPY | 151.428% |
| Linical Co., Ltd. | 14.98 JPY | 681.909% |
| Trans Genic Inc. | 0.24 JPY | 36420.833% |
| MEDINET Co., Ltd. | -6.65 JPY | -1210.827% |
| Soiken Holdings Inc. | -25.32 JPY | -244.273% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | 663.478% |
| AnGes, Inc. | -39.29 JPY | -121.863% |
| OncoTherapy Science, Inc. | -6.05 JPY | -1340.826% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 534.763% |
| NanoCarrier Co., Ltd. | -11.10 JPY | -685.315% |
| Carna Biosciences, Inc. | -68.62 JPY | -27.033% |
| CanBas Co., Ltd. | -67.87 JPY | -28.437% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | -241.041% |
| RaQualia Pharma Inc. | -14.98 JPY | -481.909% |
| Chiome Bioscience Inc. | -24.62 JPY | -254.062% |
| Kidswell Bio Corporation | -40.23 JPY | -116.679% |
| PeptiDream Inc. | 23.41 JPY | 472.362% |
| Oncolys BioPharma Inc. | -108.92 JPY | 19.969% |
| Ribomic Inc. | -28.70 JPY | -203.728% |
| SanBio Company Limited | -40.48 JPY | -115.341% |
| Healios K.K. | -56.22 JPY | -55.052% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | -378.693% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | -225.383% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 56.134% |
| StemRIM | -32.98 JPY | -164.312% |
| CellSource Co., Ltd. | 48.88 JPY | 278.335% |
| FunPep Company Limited | -39.63 JPY | -119.96% |
| Kringle Pharma, Inc. | -158.46 JPY | 44.989% |
| Stella Pharma Corporation | -24.66 JPY | -253.487% |
| TMS Co., Ltd. | -26.02 JPY | -235.012% |
| Noile-Immune Biotech Inc. | -27.25 JPY | -219.89% |
| Cuorips Inc. | -85.87 JPY | -1.514% |
| K Pharma,Inc. | 22.43 JPY | 488.631% |
| Takara Bio Inc. | 12.29 JPY | 809.276% |
| ReproCELL Incorporated | -0.37 JPY | -23459.459% |
| PhoenixBio Co., Ltd. | 6.88 JPY | 1367.006% |
| StemCell Institute Inc. | 30.25 JPY | 388.165% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | 2569.405% |
| CellSeed Inc. | -29.43 JPY | -196.194% |